Exploring Psychometric Properties of a New Version of the 6MWT in the Acute Stroke Population
Not Applicable
Terminated
- Conditions
- Acute Stroke
- Registration Number
- NCT04515693
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to assess inter- and intra-rater reliability of the 6MWT in people with acute stroke who require various levels of assistance with walking.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
- At least 18 years old
- Primary diagnosis of an acute or hemorrhagic stroke
- Admitted into the acute or acute rehab setting and is appropriate for physical therapy services.
- Can ambulate with 1 person assistance and a device as needed, with no more than maximal assistance required. The patient must be able to independently advance the lower extremity forward, but can receive maximal assistance for blocking, bracing or postural control during ambulation.
- Can stand and/or ambulate for at least 6 minutes
Exclusion Criteria
- Hemodynamically unstable
- Unstable medical co-morbidities such as: active bleeding, recurring seizures, uncontrolled hypertension (permissive HTN orders ok)
- Patients with bilateral acute stroke
- Patients who are unable to follow 1 step commands as determined by the screening physiatrist
- Orthopedic co-morbidities that place a weight-bearing restriction on the lower extremities such as acute fracture, joint replacement, or other musculoskeletal injury
- Any other condition that would limit a patient's ability to remain in a standing position with assistance for 6 minutes at a time.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method 6 Minute walk test 8 minutes (2 minutes for set-up, 6 minutes to execute) walking endurance assessment measured in meters of total distance completed over 6 minutes
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie gait recovery in acute stroke patients during the 6MWT?
How does the modified 6MWT compare to standard stroke rehabilitation assessments in clinical practice?
Are there specific biomarkers that correlate with walking capacity improvements in post-stroke populations?
What adverse events are associated with treadmill-based 6MWT in acute stroke rehabilitation?
How do combination therapies like CIMT and 6MWT influence functional outcomes in acute stroke patients?
Trial Locations
- Locations (1)
Mayo Clinic in Arizona
🇺🇸Scottsdale, Arizona, United States
Mayo Clinic in Arizona🇺🇸Scottsdale, Arizona, United States